Drug- Induced Pneumonitis: A Rare Complication of Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukemia

QR Code

Drug- Induced Pneumonitis: A Rare Complication of Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukemia

None

Saved in:

Bibliographic Details
Main Authors:	Lazareva, O.V., Turkina, A.G.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25656
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A rare case of eye complications of gastric stromal tumor treatment using imatinib mesylate
by: E. B. Myakoshina, et al.
Published: (2020-09-01)

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
by: Takahashi, Naoto, et al.
Published: (2012)

Chronic myeloid leukemia — before and after imatinib (part II)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

The Mechanisms of Resistance to Tyrosine Kinase Inhibitor Imatinib Therapy of Chronic Myeloid Leukemia
by: S. I. Kutsev, et al.
Published: (2010-06-01)

Column chromatography USED in purification of genotoxic impurity sample of imatinib mesylate substance
by: V. I. Krylov, et al.
Published: (2018-02-01)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)

Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01)

Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®)
by: L. A. Antipova, et al.
Published: (2022-11-01)

Anuric Acute Kidney Injury in Chronic Myeloid Leukemia: A Rare Complication Case
by: Angela Kimberly Tjahjadi, et al.
Published: (2025-01-01)

Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01)

PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India
by: Sameer Ahmad Guru, et al.
Published: (2017-10-01)

ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming
by: Lan Yang, et al.
Published: (2025-07-01)

Long-Term Safety and Efficacy of Imatinib in Chronic Myeloid Leukemia: Real-World Evidence from a Single-Center Study
by: İsmail Can Kendir, et al.
Published: (2025-06-01)

Treatment-free remission in patients with chronic myeloid leukemia: literature review
by: A. N. Petrova, et al.
Published: (2019-10-01)

Impact of non-coding RNAs on resistance to imatinib in chronic myelogenous leukemia
by: Fatemeh Ensafi Talemi, et al.
Published: (2025-01-01)

Serum Levels of Advanced Oxidation Protein Products and some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib
by: Ikhlas Khammas, et al.
Published: (2025-06-01)

Chronic myeloid leukemia in a patient with beta thalassemia major: a rare presentation
by: Alyna Hafeez, et al.
Published: (2025-07-01)

MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE
by: Sameen Shahid, et al.
Published: (2024-03-01)

Methotrexate-Induced Pneumonitis in a Patient with Chronic Chikungunya Arthritis
by: Jobson Lopes de Oliveira, et al.
Published: (2025-07-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

Therapy of Acute Myeloid Leukemia
by: El-Cheikh, Jean, et al.
Published: (2012)

Results of various somatic mutations detection in patients with chronic myeloid leukemia
by: E. A. Kuzmina, et al.
Published: (2024-12-01)

Pro-Inflammatory Cytokines in Patients With Chronic Phase-Chronic Myeloid Leukaemia Treated With Imatinib: Any Role in the Monitoring of Treatment Response?
by: Kehinde A. Taiwo, et al.
Published: (2025-06-01)

Evolution of therapeutic approaches in patients with chronic myeloid leukemia and T315I mutation
by: A. G. Turkina, et al.
Published: (2024-12-01)

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01)

Quality of life, symptom profile and clinical efficacy of second-line treatment with dasatinib in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: results of 2-year follow-up
by: T. I. Ionova, et al.
Published: (2015-10-01)

Paraneoplastic pemphigus - a rare autoimmune complication in patients with chronic lymphocytic leukemia
by: M. A. Volkova, et al.
Published: (2022-11-01)

The Proteasome as a Therapeutic Target in Chronic Myeloid Leukemia
by: Pérez-Roger, Ignacio, et al.
Published: (2011)

CLINICAL AND PATHOMORPHOLOGICAL EXAMINATION OF MYELOFIBROSIS IN CHRONIC MYELOID LEUKEMIA
by: T. Yu. Dolgikh, et al.
Published: (2016-02-01)

TELOMERES AND TELOMERASE ACTIVITY IN CHRONIC MYELOID LEUKEMIA (REVIEW)
by: A. S. Lyamkina, et al.
Published: (2019-03-01)

PECULIARITIES OF CHRONIC MYELOID LEUKEMIA INCIDENCE IN THE ALTAi krai
by: O. V. Efremova, et al.
Published: (2019-05-01)

CHRONIC MYELOID LEUKEMIA: EPIDEMIOLOGY AND FIFTEENTH YEARS OF THERAPY IN THE NOVOSIBIRSK REGION
by: A. S. Lyamkina, et al.
Published: (2020-03-01)